📰 Single Pill News
Single Pill News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Single Pill. Real-time updates on events, politics, business and more.
April 5, 2024
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution and mark...
April 5, 2024
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/AllianceAPONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast 05.04.2024 / 10:17 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA enter...
April 5, 2024
EQS-News: APONTIS PHARMA AG / Key word: Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications...
March 28, 2024
EQS-News: APONTIS PHARMA AG / Key word: Annual Results/Annual Report APONTIS PHARMA expects profitable growth again in 2024 28.03.2024 / 07:30 CET/CEST The issuer is...
February 6, 2024
EQS-News: APONTIS PHARMA AG / Key word: Strategic Company Decision/Restructure of Company APONTIS PHARMA successfully completes performance and efficiency improvement program...
November 8, 2023
Malaysia: Valsartan (Val)-based single-pill combination (SPC) therapies significantly reduced blood pressure (BP) in hypertensive patients, with 57% of patients achieving target BP over a prolonged...
July 27, 2023
EQSAdhoc APONTIS PHARMA AG Key word Change in ForecastProfit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and mediumterm planning for 2026 27Jul2023 2210 CETCEST Disclosure of an
July 27, 2023
APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit WarningAPONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 202627-Jul-2023 / 22:10 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service o...
July 27, 2023
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit WarningAPONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched 27.07.2023 / 22:15 CET/CESTThe issuer is solely responsible for th...
July 27, 2023
EQSAdhoc APONTIS PHARMA AG Key word Change in ForecastProfit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and mediumterm planning for 2026 27Jul2023 2210 CETCEST Disclosure of an